These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17094287

  • 21. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S.
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract] [Full Text] [Related]

  • 22. AWP reimbursement scrutinized by several states.
    Carroll J.
    Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
    [No Abstract] [Full Text] [Related]

  • 23. Reference pricing of pharmaceuticals.
    Brekke KR, Königbauer I, Straume OR.
    J Health Econ; 2007 May 01; 26(3):613-42. PubMed ID: 17188769
    [Abstract] [Full Text] [Related]

  • 24. Pricing increases for cancer drugs sparks investigation.
    Venkatesan P.
    Lancet Oncol; 2017 Jul 01; 18(7):e372. PubMed ID: 28552213
    [No Abstract] [Full Text] [Related]

  • 25. Correcting Hatch-Waxman.
    Fernandes M.
    Health Aff (Millwood); 2008 Jul 01; 27(3):902-3; author reply 903. PubMed ID: 18475000
    [No Abstract] [Full Text] [Related]

  • 26. Brand versus generic medications: the money, the patient and the research.
    Blier P.
    J Psychiatry Neurosci; 2003 May 01; 28(3):167-8. PubMed ID: 12790156
    [No Abstract] [Full Text] [Related]

  • 27. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G.
    Lakartidningen; 2003 Oct 30; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract] [Full Text] [Related]

  • 28. Prescription drugs and health care reform.
    Gibaldi M.
    Pharmacotherapy; 1993 Oct 30; 13(6):583-9. PubMed ID: 8302681
    [No Abstract] [Full Text] [Related]

  • 29. India's pharmaceutical industry: hype or high tech take-off?
    Malhotra P, Lofgren H.
    Aust Health Rev; 2004 Nov 08; 28(2):182-93. PubMed ID: 15527398
    [Abstract] [Full Text] [Related]

  • 30. Improving the PPI sample for prescription pharmaceuticals.
    Kelly GG.
    Mon Labor Rev; 1997 Oct 08; 120(10):10-7. PubMed ID: 10176326
    [No Abstract] [Full Text] [Related]

  • 31. Are we living in the end of the blockbuster drug era?
    Debnath B, Al-Mawsawi LQ, Neamati N.
    Drug News Perspect; 2010 Dec 08; 23(10):670-84. PubMed ID: 21180653
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A trade agreement's impact on access to generic drugs.
    Shaffer ER, Brenner JE.
    Health Aff (Millwood); 2009 Dec 08; 28(5):w957-68. PubMed ID: 19706626
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Screaming for relief.
    Cooper M.
    Time; 1999 Nov 22; 154(21):38-42, 44. PubMed ID: 10622838
    [No Abstract] [Full Text] [Related]

  • 37. Generics offer pharmacy plans specific benefits.
    Reinke T.
    Manag Care; 2010 Feb 22; 19(2):28-30, 34. PubMed ID: 20550049
    [No Abstract] [Full Text] [Related]

  • 38. [Now no new drugs will be developed!].
    Lafolie P.
    Lakartidningen; 2010 Feb 22; 103(4):225. PubMed ID: 16491556
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS.
    Nurs Econ; 2005 Feb 22; 23(6):307-11, 279. PubMed ID: 16459902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.